Vertex Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
19:00
/
50%
€417.90
Target price
13.02.27
€455.79
Performance (%)
-0.34%
Price
20:59
€416.50
Summary
This prediction is currently active. Since the start of the prediction for Vertex Pharmaceuticals Inc. the price has only changed by -0.34%. This prediction currently runs until 13.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | -0.34% |
| iShares Core DAX® | 1.927% |
| iShares Nasdaq 100 | -0.184% |
| iShares Nikkei 225® | 7.076% |
| iShares S&P 500 | -0.201% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $541.00 price target on by analysts at Royal Bank Of Canada. They now have an "outperform" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€391.10
22.01.26
22.01.26
€467.05
22.01.27
22.01.27
7.54%
20:59
20:59
